3 Dec 2019 16:54
Mereo BioPharma Group plc
("Mereo" or the "Company")
Notification of PDMR Dealing
London, December 03, 2019 - Mereo BioPharma Group plc (AIM: MPH, NASDAQ: MREO), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on December 02, 2019, John Richard, Head of Corporate Development, purchased 3500 American Depositary Shares (ADSs) at an aggregated price of USD 2.201 per ADS.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
1 | Details of the person discharging managerial responsibilities
| |||||||||||||||||
a) | Name | John Richard
| ||||||||||||||||
2 | Reason for the notification | |||||||||||||||||
a) | Position/status | Head of Corporate Development
| ||||||||||||||||
b) | Initial notification/ Amendment | Initial notification | ||||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||
a) | Name | Mereo BioPharma Group plc
| ||||||||||||||||
b) | LEI | 213800U8JQHIJOS5AS09
| ||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||
a) | Description of the financial instrument, type of instrument and identification code | AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
| ||||||||||||||||
b) | Nature of the transaction | PURCHASE OF ADS | ||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||
d) | Aggregated information: volume, Price | Aggregated volume: 3500 Aggregated price: USD2.201 | ||||||||||||||||
e) | Date of the transaction | 2019-12-02 | ||||||||||||||||
f) | Place of the transaction | XNMS | ||||||||||||||||